Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Oštrbenk

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|September 24, 2017
Elsevier’s CiteScore index values for Acta Dermatovenerologica Alpina, Pannonica et Adriatica: a 2016 updateAnja Šterbenc, Anja Oštrbenk
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 15, 2015
Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica: 1992-2013Anja Oštrbenk, Mario Poljak
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|July 10, 2013
The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studiesMario Poljak, Anja Oštrbenk
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|September 23, 2014
Specificity of the Linear Array HPV Genotyping Test for detecting human papillomavirus genotype 52 (HPV-52)Anja Oštrbenk, Boštjan J Kocjan, Mario Poljak
Journal of Medical Virology|July 1, 2014
Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screeningVeronika Učakar, Mario Poljak, Anja Oštrbenk, et al.
Journal of Clinical Microbiology|September 14, 2018
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 FrameworkAnja Oštrbenk, Lan Xu, Marc Arbyn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 8, 2025
The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator testAnja Oštrbenk, Helle Pedersen, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 15, 2017
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT frameworkLan Xu, Anja Oštrbenk, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 21, 2021
Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening settingAnja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, et al.
Journal of Clinical Microbiology|April 5, 2020
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 FrameworkLan Xu, Anja Oštrbenk Valenčak, Mario Poljak, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|September 24, 2017
Elsevier’s CiteScore index values for Acta Dermatovenerologica Alpina, Pannonica et Adriatica: a 2016 updateAnja Šterbenc, Anja Oštrbenk
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 15, 2015
Citation analysis of Acta Dermatovenerologica Alpina, Pannonica et Adriatica: 1992-2013Anja Oštrbenk, Mario Poljak
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|July 10, 2013
The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical cancer screening in women 30 years and older: a review of validation studiesMario Poljak, Anja Oštrbenk
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|September 23, 2014
Specificity of the Linear Array HPV Genotyping Test for detecting human papillomavirus genotype 52 (HPV-52)Anja Oštrbenk, Boštjan J Kocjan, Mario Poljak
Journal of Medical Virology|July 1, 2014
Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screeningVeronika Učakar, Mario Poljak, Anja Oštrbenk, et al.
Journal of Clinical Microbiology|September 14, 2018
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 FrameworkAnja Oštrbenk, Lan Xu, Marc Arbyn, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 8, 2025
The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator testAnja Oštrbenk, Helle Pedersen, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 15, 2017
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT frameworkLan Xu, Anja Oštrbenk, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 21, 2021
Comparison of the clinical and analytical performance of Alinity m HR HPV and cobas 4800 HPV assays in a population-based screening settingAnja Oštrbenk Valenčak, Alexander Bertram, Arndt Gröning, et al.
Journal of Clinical Microbiology|April 5, 2020
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 FrameworkLan Xu, Anja Oštrbenk Valenčak, Mario Poljak, et al.
Pageof 5